Resultados de la búsqueda
Moreno G, Vicent L, Rosillo N, Delgado J, Cerro EPD, Bueno H. Do sex and gender aspects influence non-adherence to secondary prevention measures after myocardial infarction? Am J Prev Cardiol (2024) 19:100713
Hernandez Sevillano J, Babagoli MA, Chen Y, Liu SH, Mellacheruvu P, Johnson J, Ibanez B, Lorenzo O, Mechanick JI. Higher neighborhood disadvantage is associated with weaker interactions among cardiometabolic drivers. Int J Cardiol Cardiovasc Risk Prev (2024) 23:200322
Garcia-Pavia P, Damy T, Piriou N, Barriales-Villa R, Cappelli F, Bahus C, Munteanu C, Keohane D, Mallaina P, Elliott P; TTRACK investigators. Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy. ESC Heart Fail (2024) 11:4314-4324
Kerrigan L, Edgar K, Russell-Hallinan A, Cappa O, Glezeva N, Galan-Arriola C, Oliver E, Ibanez B, Baugh J, Collier P, Ledwidge M, McDonald K, Simpson D, Das S, Grieve DJ, Watson CJ. Integrin beta-like 1 is regulated by DNA methylation and increased in heart failure patients. ESC Heart Fail (2024) 12:150-165
Vicent L, Rosillo N, Vélez J, Moreno G, Pérez P, Bernal JL, Seara G, Salguero-Bodes R, Arribas F, Bueno H. Profiling heart failure with preserved or mildly reduced ejection fraction by cluster analysis. Eur Heart J Qual Care Clin Outcomes (2024) 11:140-148
Camblor Blasco A, Devesa A, Nieto Roca L, Gómez-Talavera S, Lumpuy-Castillo J, Pello Lázaro AM, Llanos Jiménez L, Sánchez González J, Lorenzo Ó, Tuñón J, Ibáñez B, Aceña Á. Effect of Diflunisal in Patients with Transthyretin Cardiomyopathy: A Pilot Study. J Clin Med (2024) 13:5032.
Rivero-Santana B, Galán C, Pérez-Martínez C, Ibañez B, Pérez de Prado A, Fernández-Velasco M, Moreno R, Jurado-Roman A. ELLIS Study: Comparative Analysis of Excimer Laser Coronary Angioplasty and Intravascular Lithotripsy on Drug-Eluting Stent as Assessed by Scanning Electron Microscopy. Circ Cardiovasc Interv (2024) 17:e014505.
Pascual-Figal D, Bayes-Genis A. Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review. Front Cardiovasc Med (2024) 11:1439696
Link to the full text in Repisalud
Link to the full text in Repisalud
Núñez E, Gómez-Serrano M, Calvo E, Bonzon-Kulichenko E, Trevisan-Herraz M, Rodríguez JM, García-Marqués F, Magni R, Lara-Pezzi E, Martín-Ventura JL, Camafeita E, Vázquez J. A Multiplexed Quantitative Proteomics Approach to the Human Plasma Protein Signature. Biomedicines (2024) 12:2118
Link to the full text in Repisalud
Link to the full text in Repisalud
Párraga R, Real C, Jiménez-Mazuecos J, Vázquez-Álvarez ME, Valero E, Velázquez M, Tébar D, Salvatella N, Rumiz E, Ruiz Quevedo V, Sabatel-Pérez F, Amat-Santos I, Lozano I, Elizondo I, Andrés-Morist A, Núñez-Gil I, Portero JJ, Gonzalo N, Juárez Fernández M, Viana-Tejedor A, Ferrera C, Salinas P. New risk classification adapting SCAI shock stages to patients with pulmonary embolism (RISA-PE). Minerva Cardiol Angiol (2024) 73:304-314






